Thermo Fisher Scientific Awarded Patent for Cell Factory System
Thermo Fisher Scientific Inc. announced that it has been awarded a patent by the United States Patent and Trademark Office on its Thermo Scientific Nunc Cell Factory System with Active Gassing, recognizing the device’s unique gas distribution system. Developed for cells that require a high or low level of oxygen for optimal growth or are pH sensitive, the system provides a controlled atmosphere by distributing a user-specified gas mixture that is actively pumped through an attached filtration device.
Nunc™ Cell Factory™ Systems are multi-layer cell-culture vessels that provide a large surface area for growing anchorage-dependent cells in a space-saving footprint. The addition of the active gassing system ensures a controlled, contamination-free atmosphere in each culture tray, and the patented system achieves greater yields and optimizes production capacity without changing cell-culture platforms.
“The Thermo Scientific Nunc Cell Factory System was the first to enter the disposable bioreactor market, and it provides many advantages, including easy up-scaling, low risk of contamination and reduced lifetime operating costs,” said Jill Staggert, product marketing manager, bioproduction, at Thermo Fisher. “We also customize ports and provide pre-assembled tubing configurations to support specific applications, as well as offer a wide range of accessories, including equipment such as shakers, manipulators, incubators, shelf systems, peristaltic pumps, single-use bioreactors and more. Thermo Fisher is dedicated to being the leader in bioproduction processing by offering a full range of complementary production cell culture products.”
Other news from the department research and development
Most read news
More news from our other portals
Last viewed contents
Early Screening, Innovative Solutions to Underline Importance of ADME/Tox Technologies in Successful Drug Development - Considerable Time, Cost Savings to Accrue from Advanced ADME/Tox Technologies
X-ray pulses uncover free nanoparticles for the first time in 3-D - 'Super microscope' reveals unexpected variety of shapes
Fluorotechnics appoints European biotech veteran Lars Utterman as non-executive director
Wyatt seeks $25 million in damages from Malvern for willful infringement
VIAFLO Corporation and INTEGRA Biosciences enter into Strategic Partnership
Detect Alzheimer's disease as early as 20 years before the onset? - New blood test shows great promise in the diagnosis of Alzheimer's disease
Pronota and Molecuence announce collaboration in protein biomarker discovery
Oxford Instruments strengthens links with Taiwan through mutual co-operation and understanding
UMC Utrecht and VectorY Therapeutics collaborate in ALS Biomarker Study - Finding these biomarkers is expected to help diagnose ALS and monitor disease progression and improve the design of future clinical studie
SemBioSys Genetics and Syngenta Enter Into Agreement on Protein and Antibody Purification Technology - Deal between biotech companies will strengthen capabilities in biopharmaceuticals
